Acetate–FFAR2 signaling induces neutrophil-derived IL-22 to protect against colitis
Short-chain fatty acids (SCFAs) produced by gut microbiota are key modulators of intestinal homeostasis and immune responses. Although their anti-inflammatory roles are well established, the mechanisms by which SCFAs-FFAR2 shapes neutrophil function and influences intestinal inflammation remain unclear. Here, we demonstrate that dietary fiber or acetate protect mice from DSS-induced colitis despite increasing neutrophil infiltration into the intestinal tissue. Importantly, neutrophils are required for the protective effects of acetate, which are also dependent on FFAR2 signaling and IL-22. Neutrophil-specific deletion of FFAR2 impairs IL-22 responses, increases epithelial damage, and exacerbates colitis, while administration of recombinant IL-22 is sufficient to restore acetate protection in this context. Analysis of human ulcerative colitis biopsies reveals increased FFAR2 + neutrophils correlating with IL-22-related gene signatures. These findings indicate that acetate–FFAR2–neutrophil–IL-22 axis modulates intestinal inflammation, revealing a metabolic mechanism that links microbiota-derived signals to mucosal protection and highlighting potential therapeutic targets for inflammatory bowel diseases.
Authors
- Arilson Bernardo dos Santos Pereira Gomes (ORCID: https://orcid.org/0000-0003-0315-1536)
- Beatriz Burger (ORCID: https://orcid.org/0000-0002-8666-9455)
- Mariane Font Fernandes (ORCID: https://orcid.org/0000-0002-0262-4509)
- José Luís Fachi (ORCID: https://orcid.org/0000-0002-1035-5193)
- Brian Thomas Layden (ORCID: https://orcid.org/0000-0003-2176-5654)
- Susan Gilfillan (ORCID: https://orcid.org/0000-0003-1672-0996)
- Marco Aurélio Ramirez Vinolo (ORCID: https://orcid.org/0000-0003-1335-760X)
- Tihana Tršan (ORCID: https://orcid.org/0000-0002-7549-2885)
- Tahila Andrighetti (ORCID: https://orcid.org/0000-0003-3402-8338)
- Siyan “Stewart” Cao (ORCID: https://orcid.org/0000-0002-3740-2164)
- Vinícius Dias Nirello (ORCID: https://orcid.org/0000-0001-7358-042X)
- Marco Colonna (ORCID: https://orcid.org/0000-0001-5222-4987)
- Helder Carvalho de Assis (ORCID: https://orcid.org/0000-0003-3988-5582)
- Krzysztof L. Hyrc (ORCID: https://orcid.org/0000-0002-8830-6324)
- Laís Passariello Pral (ORCID: https://orcid.org/0000-0002-3008-0465)
- André Luiz Amorim da Costa (ORCID: https://orcid.org/0000-0002-2170-7940)
- Pollyana Ribeiro Castro (ORCID: https://orcid.org/0000-0002-1404-6873)
- Valquíria Aparecida Matheus (ORCID: https://orcid.org/0000-0001-8528-8004)
- Sarah de Oliveira (ORCID: https://orcid.org/0000-0002-9449-9740)
- Maria Eduarda dos Santos Celeghini
- Nathalia Araujo Hall
- Ana Júlia Sampaio De Sousa
- Bruna Toledo Nunes Pereira
Institutions
- Universidade Federal de Minas Gerais (BR)
- Universidade Estadual de Campinas (UNICAMP) (BR)
- Virginia Commonwealth University (US)
- Washington University in St. Louis (US)
- University of Illinois Chicago (US)
- Massachusetts General Hospital (US)
- Hope Center for Neurological Disorders (US)
- Center for Computational and Integrative Biology, Massachusetts General Hospital (US)
Publication Details
- Journal
- Proceedings of the National Academy of Sciences
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1073/pnas.2606185123
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pew Charitable Trusts
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Universidade de São Paulo
- National Institutes of Health